Risk factors for tumor recurrence in all patients included presence of hepatitis B virus (HBV) infection (p = 0.038), higher AFP model score (p = 0.001), longer total duration of graft ischemia (p = 0.004), and younger donor age (p = 0.016), while standard HCC-related factors were not significantly associated with the risk of tumor recurrence (Table 2). The gene discussed is AFP; the disease is neoplasm.